Intro

This chapter explores genetic syndromes that elevate the risk of malignancy, particularly renal cell carcinoma. It highlights the importance of awareness and early detection of conditions like von Hippel-Lindau, as well as the promising role of the drug Belzutafan in treatment strategies.